These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6801211)

  • 1. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
    Fagius J; Jameson S
    J Neurol Neurosurg Psychiatry; 1981 Nov; 44(11):991-1001. PubMed ID: 6801211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of an aldose reductase inhibitor in diabetic neuropathy.
    Handelsman DJ; Turtle JR
    Diabetes; 1981 Jun; 30(6):459-64. PubMed ID: 6785131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.
    Lewin IG; O'Brien IA; Morgan MH; Corrall RJ
    Diabetologia; 1984 Jun; 26(6):445-8. PubMed ID: 6432615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibition: studies with alrestatin.
    Gabbay KH; Spack N; Loo S; Hirsch HJ; Ackil AA
    Metabolism; 1979 Apr; 28(4 Suppl 1):471-6. PubMed ID: 122298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report.
    Culebras A; Alió J; Herrera JL; López-Fraile MI
    Arch Neurol; 1981 Feb; 38(2):133-4. PubMed ID: 6781454
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial.
    Fagius J; Brattberg A; Jameson S; Berne C
    Diabetologia; 1985 Jun; 28(6):323-9. PubMed ID: 3930330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
    Jaspan JB; Herold K; Bartkus C
    Am J Med; 1985 Nov; 79(5A):24-37. PubMed ID: 3000176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.
    Jaspan JB; Towle VL; Maselli R; Herold K
    Metabolism; 1986 Apr; 35(4 Suppl 1):83-92. PubMed ID: 3083212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function.
    Martyn CN; Reid W; Young RJ; Ewing DJ; Clarke BF
    Diabetes; 1987 Sep; 36(9):987-90. PubMed ID: 3111914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
    N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function.
    Jaspan J; Maselli R; Herold K; Bartkus C
    Lancet; 1983 Oct; 2(8353):758-62. PubMed ID: 6137601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
    Christensen JE; Varnek L; Gregersen G
    Acta Neurol Scand; 1985 Feb; 71(2):164-7. PubMed ID: 3920861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 14. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil.
    O'Hare JP; Morgan MH; Alden P; Chissel S; O'Brien IA; Corrall RJ
    Diabet Med; 1988 Sep; 5(6):537-42. PubMed ID: 2974776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged aldose reductase inhibition in chronic peripheral diabetic neuropathy: effects on microangiopathy.
    Jennings PE; Nightingale S; Le Guen C; Lawson N; Williamson JR; Hoffman P; Barnett AH
    Diabet Med; 1990 Jan; 7(1):63-8. PubMed ID: 2137066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can aldose reductase inhibition ameliorate diabetic neuropathy?
    González ER
    JAMA; 1981 Sep; 246(11):1169-70. PubMed ID: 6790734
    [No Abstract]   [Full Text] [Related]  

  • 17. Autonomic and peripheral nerve function in early diabetic neuropathy. Possible influence of a novel aldose reductase inhibitor on autonomic function.
    Sundkvist G; Lilja B; Rosén I; Agardh CD
    Acta Med Scand; 1987; 221(5):445-53. PubMed ID: 3111179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of aldose reductase in human diabetic neuropathy.
    Jaspan J
    Drugs; 1986; 32 Suppl 2():23-9. PubMed ID: 2431859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.
    Sima AA; Greene DA; Brown MB; Hohman TC; Hicks D; Graepel GJ; Bochenek WJ; Beg M; Gonen B
    J Diabetes Complications; 1993; 7(3):157-69. PubMed ID: 8343610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement].
    Shimada H; Miki T; Kyogoku I; Kawagishi T; Inaba M; Okuno Y; Nishizawa Y; Morii H
    No To Shinkei; 1998 Sep; 50(9):817-20. PubMed ID: 9789304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.